CVS Health vs Regeneron Pharmaceuticals

CVS Health (CVS), health care, and Regeneron Pharmaceuticals (REGN), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

CVS Health is worth $111B on the stock market and Regeneron Pharmaceuticals $99.2B: CVS Health is valued at 12% more. CVS Health trades at 10.1 times earnings and Regeneron Pharmaceuticals at 21.2; operating margins in their latest fiscal years were 1.16% and 24.9%. Over the past year CVS Health's share price has moved +13.7% and Regeneron Pharmaceuticals's +31.3%.

Key facts

CVS Health market value
$111B
Regeneron Pharmaceuticals market value
$99.2B
CVS Health P/E
10.1
Regeneron Pharmaceuticals P/E
21.2
CVS Health revenue
$402.1BFY to 2025-12-31
Regeneron Pharmaceuticals revenue
$14.3BFY to 2025-12-31
Superinvestors holding both
5

Market values as of .

CVS Health vs Regeneron Pharmaceuticals: every measure side by side
Measure CVS Health Regeneron Pharmaceuticals
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$111Bhigher$99.2Blower
Revenue$402.1Bhigher$14.3Blower
Earnings$1.8Blower$4.5Bhigher
Employees219,000higher15,410lower
Total assets$253.5Bhigher$40.6Blower
Valuation
P/E10.1lower21.2higher
P/S0.3lower6.9higher
P/B1.4lower2.9higher
Dividend yield3.00%higher0.39%lower
Profitability
Operating margin1.16%lower24.9%higher
Balance sheet
Net assets$75.2Bhigher$31.3Blower
Total liabilities$178.2Bhigher$9.3Blower
Total debt$64.6Bhigher$2Blower
Cash on hand$8.5Bhigher$3.1Blower
Price change
Today-2.09%lower+0.66%higher
1 year+13.7%lower+31.3%higher

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Percentages are each holding's share of that investor's reported portfolio (under "Both": CVS Health / Regeneron Pharmaceuticals). Who owns CVS · Who owns REGN

Further comparisons

Learn

Questions and answers

Which is bigger, CVS Health or Regeneron Pharmaceuticals?

By market value, CVS Health is the larger: $111B against $99.2B for Regeneron Pharmaceuticals. By revenue in its latest fiscal year, CVS Health is the larger: $402.1B against $14.3B for Regeneron Pharmaceuticals.

Which has the higher P/E ratio?

Regeneron Pharmaceuticals: 21.2, against 10.1 for CVS Health. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher operating margin?

Regeneron Pharmaceuticals: 24.9%, against 1.16% for CVS Health. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has the higher dividend yield?

CVS Health: 3.00%, against 0.39% for Regeneron Pharmaceuticals. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which has more debt?

CVS Health: $64.6B, against $2B for Regeneron Pharmaceuticals. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both CVS Health and Regeneron Pharmaceuticals?

In their latest 13F filings, Dodge & Cox team, Josef Lakonishok, Jim Simons (1938–2024), Ray Dalio (founder) and Jeremy Grantham (co-founder) hold both.

Cite this page

Funkfolio, “CVS Health vs Regeneron Pharmaceuticals”, data as of 17 November 2026. https://funkfolio.com/compare/cvs-vs-regn

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.